MERCK Kommanditgesellschaft auf Aktien (MRK.DE)
EUR 140.9
(0.61%)
EUR 140.9
(0.61%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 9.94 Billion EUR | -4.4% |
| 2022 | 10.39 Billion EUR | -3.42% |
| 2021 | 10.76 Billion EUR | -10.57% |
| 2020 | 12.03 Billion EUR | -8.23% |
| 2019 | 13.11 Billion EUR | 48.99% |
| 2018 | 8.8 Billion EUR | -17.78% |
| 2017 | 10.7 Billion EUR | -14.1% |
| 2016 | 12.46 Billion EUR | -7.85% |
| 2015 | 13.52 Billion EUR | 140.01% |
| 2014 | 5.63 Billion EUR | 52.44% |
| 2013 | 3.69 Billion EUR | -13.88% |
| 2012 | 4.29 Billion EUR | 0.0% |
| 2011 | - EUR | 0.0% |
| 2010 | - EUR | 0.0% |
| 2009 | - EUR | 0.0% |
| 2008 | - EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| 2004 | - EUR | 0.0% |
| 2003 | - EUR | 0.0% |
| 2002 | - EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 10.74 Billion EUR | 7.99% |
| 2024 Q1 | 9.95 Billion EUR | 0.13% |
| 2023 FY | 9.94 Billion EUR | -4.4% |
| 2023 Q4 | 9.94 Billion EUR | -9.26% |
| 2023 Q3 | 10.95 Billion EUR | -2.05% |
| 2023 Q1 | 10.64 Billion EUR | 2.37% |
| 2023 Q2 | 11.18 Billion EUR | 5.08% |
| 2022 Q3 | 11.05 Billion EUR | -6.38% |
| 2022 FY | 10.39 Billion EUR | -3.42% |
| 2022 Q2 | 11.8 Billion EUR | 11.02% |
| 2022 Q1 | 10.63 Billion EUR | -1.25% |
| 2022 Q4 | 10.39 Billion EUR | -5.9% |
| 2021 Q2 | 11.99 Billion EUR | -2.83% |
| 2021 Q4 | 10.76 Billion EUR | -1.81% |
| 2021 Q3 | 10.96 Billion EUR | -8.62% |
| 2021 FY | 10.76 Billion EUR | -10.57% |
| 2021 Q1 | 12.34 Billion EUR | 2.57% |
| 2020 Q2 | 14.09 Billion EUR | 1.7% |
| 2020 Q1 | 13.85 Billion EUR | 5.6% |
| 2020 Q3 | 13.66 Billion EUR | -3.05% |
| 2020 Q4 | 12.03 Billion EUR | -11.87% |
| 2020 FY | 12.03 Billion EUR | -8.23% |
| 2019 Q4 | 13.11 Billion EUR | 4.58% |
| 2019 Q1 | 9.49 Billion EUR | 7.78% |
| 2019 Q2 | 11.43 Billion EUR | 20.44% |
| 2019 Q3 | 12.54 Billion EUR | 9.75% |
| 2019 FY | 13.11 Billion EUR | 48.99% |
| 2018 FY | 8.8 Billion EUR | -17.78% |
| 2018 Q1 | 10.79 Billion EUR | 0.79% |
| 2018 Q2 | 11.4 Billion EUR | 5.64% |
| 2018 Q3 | 11.06 Billion EUR | -3.0% |
| 2018 Q4 | 8.8 Billion EUR | -20.4% |
| 2017 Q1 | 12.25 Billion EUR | -1.67% |
| 2017 Q4 | 10.7 Billion EUR | -6.31% |
| 2017 Q3 | 11.43 Billion EUR | -7.67% |
| 2017 Q2 | 12.38 Billion EUR | 0.99% |
| 2017 FY | 10.7 Billion EUR | -14.1% |
| 2016 Q4 | 12.46 Billion EUR | -1.17% |
| 2016 Q3 | 12.61 Billion EUR | -5.42% |
| 2016 Q2 | 13.33 Billion EUR | 2.11% |
| 2016 FY | 12.46 Billion EUR | -7.85% |
| 2016 Q1 | 13.06 Billion EUR | -3.46% |
| 2015 Q2 | 8.11 Billion EUR | 2.49% |
| 2015 Q3 | 10.32 Billion EUR | 27.21% |
| 2015 Q1 | 7.91 Billion EUR | 40.47% |
| 2015 FY | 13.52 Billion EUR | 140.01% |
| 2015 Q4 | 13.52 Billion EUR | 31.05% |
| 2014 FY | 5.63 Billion EUR | 52.44% |
| 2014 Q2 | 4.02 Billion EUR | 7.87% |
| 2014 Q1 | 3.72 Billion EUR | 0.86% |
| 2014 Q4 | 5.63 Billion EUR | 34.97% |
| 2014 Q3 | 4.17 Billion EUR | 3.81% |
| 2013 Q1 | 4.46 Billion EUR | 4.06% |
| 2013 FY | 3.69 Billion EUR | -13.88% |
| 2013 Q4 | 3.69 Billion EUR | -3.77% |
| 2013 Q3 | 3.84 Billion EUR | -17.22% |
| 2013 Q2 | 4.64 Billion EUR | 3.89% |
| 2012 Q3 | - EUR | 0.0% |
| 2012 Q4 | 4.29 Billion EUR | 0.0% |
| 2012 FY | 4.29 Billion EUR | 0.0% |
| 2012 Q1 | - EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2011 Q3 | - EUR | 0.0% |
| 2011 FY | - EUR | 0.0% |
| 2011 Q1 | - EUR | 0.0% |
| 2011 Q2 | - EUR | 0.0% |
| 2011 Q4 | - EUR | 0.0% |
| 2010 Q2 | - EUR | 0.0% |
| 2010 Q1 | - EUR | 0.0% |
| 2010 FY | - EUR | 0.0% |
| 2010 Q4 | - EUR | 0.0% |
| 2010 Q3 | - EUR | 0.0% |
| 2009 FY | - EUR | 0.0% |
| 2009 Q4 | - EUR | 0.0% |
| 2008 FY | - EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| 2004 FY | - EUR | 0.0% |
| 2003 FY | - EUR | 0.0% |
| 2002 FY | - EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| MPH Health Care AG | 13.05 Million EUR | -76050.278% |
| Apontis Pharma AG | 6 Million EUR | -165583.333% |
| Dermapharm Holding SE | 1.08 Billion EUR | -820.132% |
| Evotec SE | 626.19 Million EUR | -1487.517% |
| PharmaSGP Holding SE | 73.97 Million EUR | -13337.96% |
| SynBiotic SE | 3.68 Million EUR | -270017.226% |